Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gorlin Syndrome”

43 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 43 results

Not applicableStudy completedNCT02100371
What this trial is testing

Study of BMS-833923 in Two Specific Patients With Basal Cell Nevus Syndrome

Who this might be right for
Basal Cell Nevus Syndrome
University Health Network, Toronto 2
Testing effectiveness (Phase 2)Study completedNCT00023621
What this trial is testing

Celecoxib in Preventing Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome

Who this might be right for
Non-melanomatous Skin Cancer
University of California, San Francisco 60
Large-scale testing (Phase 3)Ended earlyNCT04308395
What this trial is testing

Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome)

Who this might be right for
Basal Cell Nevus Syndrome
Sol-Gel Technologies, Ltd. 108
Testing effectiveness (Phase 2)Study completedNCT00783965
What this trial is testing

Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back

Who this might be right for
Skin Carcinoma
UCSF Benioff Children's Hospital Oakland 34
Not applicableStudy completedNCT02157623
What this trial is testing

Blue vs Red Light During Levulan Based Photodynamic Therapy in Patients With Basal Cell Nevus Syndrome

Who this might be right for
Basal Cell Nevus Syndrome
Edward Maytin, MD, PhD 3
Not applicableLooking for participantsNCT04569149
What this trial is testing

Primordial Dwarfism Registry

Who this might be right for
MOPDIIMeier-Gorlin SyndromeSaul-Wilson Syndrome+4 more
Nemours Children's Clinic 200
Not applicableLooking for participantsNCT06330350
What this trial is testing

Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling

Who this might be right for
Quality of LifeIchthyosisPalmoplantar Keratoses+7 more
Maastricht University Medical Center 25
Testing effectiveness (Phase 2)Study completedNCT02354261
What this trial is testing

Open-label Trial of SUBA™-Itraconazole (SUBA-Cap) in Subjects With Basal Cell Carcinoma Nevus Syndrome (BCCNS)

Who this might be right for
Basal Cell Carcinoma in Basal Cell Nevus Syndrome
HedgePath Pharmaceuticals, Inc. 38
Large-scale testing (Phase 3)Study completedNCT06050122
What this trial is testing

Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome

Who this might be right for
Gorlin Syndrome
Sol-Gel Technologies, Ltd. 113
Not applicableLooking for participantsNCT05463757
What this trial is testing

Oral Hedgehog Inhibitors in the Treatment of Basal Cell Carcinoma in the Netherlands: a Prospective Registration Study

Who this might be right for
Basal Cell CarcinomaLocally Advanced Basal Cell CarcinomaMetastatic Basal Cell Carcinoma+8 more
Maastricht University Medical Center 80
Testing effectiveness (Phase 2)Study completedNCT02017964
What this trial is testing

Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-metastatic Desmoplastic Medulloblastoma

Who this might be right for
Desmoplastic/Nodular MedulloblastomaMedulloblastomaMedulloblastoma With Extensive Nodularity+1 more
Children's Oncology Group 26
Testing effectiveness (Phase 2)Study completedNCT02550678
What this trial is testing

The Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma

Who this might be right for
Basal Cell Nevus SyndromeSkin NeoplasmNodular Basal Cell Carcinoma of Skin
Ascend Biopharmaceuticals Ltd 16
Testing effectiveness (Phase 2)Study completedNCT04893486
What this trial is testing

CODY: A Study Evaluating The Safety And Efficacy Of QTORIN 3.9% Sirolimus Topical Gel For The Prevention Of Basal Cell Carcinomas (BCCs) In Patients With Gorlin Syndrome

Who this might be right for
BCCs in Gorlin Syndrome Patients
Palvella Therapeutics, Inc. 73
Early research (Phase 1)Looking for participantsNCT06623201
What this trial is testing

Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell Carcinomas

Who this might be right for
Basal Cell Carcinoma (BCC)
Nathalie Zeitouni 20
Large-scale testing (Phase 3)Ended earlyNCT00049959
What this trial is testing

Two Studies to Determine if Verteporfin PDT is Effective & Safe in Treating Multiple Basal Cell Carcinoma of the Skin.

Who this might be right for
Basal Cell CarcinomaNevoid Basal Cell Carcinoma SyndromeGorlin Syndrome
QLT Inc.
Testing effectiveness (Phase 2)Study completedNCT01350115
What this trial is testing

Efficacy, Safety and Pharmacokinetics of Oral LDE225 in Treatment of Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS)

Who this might be right for
Basal Cell CarcinomaGorlin SyndromeNevoid Basal Cell Carcinoma Syndrome
Novartis Pharmaceuticals 10
Testing effectiveness (Phase 2)Study completedNCT04416516
What this trial is testing

Safety and Efficacy of ASN-002 Combined With a Hedgehog Pathway Inhibitor

Who this might be right for
Basal Cell CarcinomaBasal Cell Nevus Syndrome
Ascend Biopharmaceuticals Ltd 21
Testing effectiveness (Phase 2)WithdrawnNCT03767439
What this trial is testing

Nivolumab With Vismodegib in Patients With Basal Cell Nevus Syndrome

Who this might be right for
Basal Cell Nevus Syndrome
Columbia University
Large-scale testing (Phase 3)Study completedNCT03703310
What this trial is testing

Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome (Gorlin Syndrome)

Who this might be right for
Basal Cell Nevus Syndrome
Sol-Gel Technologies, Ltd. 174
Testing effectiveness (Phase 2)Study completedNCT00961896
What this trial is testing

A Trial to Evaluate the Safety, Local Tolerability, Pharmacokinetics and Pharmacodynamics of LDE225 on Skin Basal Cell Carcinomas in Gorlin Syndrome Patients

Who this might be right for
Treatment for Basal Cell Carcinomas (BCCs) in Gorlin Syndrome Patients
Novartis Pharmaceuticals 18
Next Page